The COVID-19 pandemic has changed the practice of cardiology as we know it, leading to supplies shortages, delayed procedures, and an at-risk patient population fearful of the road ahead. How has the outbreak affected cath labs?

The primary reason behind this change is believed to be significant improvements in how healthcare providers care for stroke patients. 

The American Heart Association (AHA) has shared a detailed account of its role as the world continues to fight against the spread of the new coronavirus.

Liraglutide, a common medication used to treat type 2 diabetes (T2D), is safe to use for heart failure (HF) patients, according to new findings published in the Journal of the American College of Cardiology.

The British Heart Foundation (BHF) has published a statement warning patients with certain medical conditions, including cardiovascular diseases, to be “extra vigilant” as the new coronavirus continues to spread.

The FDA has published new requirements for the health warnings featured on cigarette packages and in cigarette advertisements.

A patient’s e-cigarette interfered with their implantable cardioverter-defibrillator (ICD) and prevented the device from properly functioning, according to a new analysis published in HeartRhythm Case Reports.

Patients with cardiovascular disease should continue taking angiotensin-converting enzyme (ACE) inhibitors and angiotensin-receptor blockers (ARBs) as prescribed if they are diagnosed with the new coronavirus (COVID-19), according to a joint statement from three medical societies.